This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 2005-0359OCv1 35/3/327    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wright, J. M. Articles by Boyle, M. P. Search for Related Content PubMed PubMed Citation Articles by Wright, J. M. Articles by Boyle, M. P.

Respiratory Epithelial Gene Expression in Patients with Mild and Severe Cystic Fibrosis Lung Disease

Department of Physiology, Department of Medicine, and Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illinois

Correspondence and requests for reprints should be addressed to Michael P. Boyle, M.D., F.C.C.P., The Johns Hopkins University School of Medicine, 1830 E. Monument Street, 5th floor, Baltimore, MD 21205. E-mail: mboyle{at}jhmi.edu

Despite having identical cystic fibrosis transmembrane conductance regulator genotypes, individuals with F508 homozygous cystic fibrosis (CF) demonstrate significant variability in severity of pulmonary disease. This investigation used high-density oligonucleotide microarray analysis of nasal respiratory epithelium to investigate the molecular basis of phenotypic differences in CF by (1) identifying differences in gene expression between F508 homozygotes in the most severe 20th percentile of lung disease by forced expiratory volume in 1 s and those in the most mild 20th percentile of lung disease and (2) identifying differences in gene expression between F508 homozygotes and age-matched non-CF control subjects. Microarray results from 23 participants (12 CF, 11 non-CF) met the strict quality control guidelines and were used for final data analysis. A total of 652 of the 11,867 genes identified as present in 75% of the samples were significantly differentially expressed in one of the three disease phenotypes: 30 in non-CF, 53 in mild CF, and 569 in severe CF. An analysis of genes differentially expressed by severity of CF lung disease demonstrated significant upregulation in severe CF of genes involved in protein ubiquination (P < 0.04), mitochondrial oxidoreductase activity (P < 0.01), and lipid metabolism (P < 0.03). Analysis of genes with decreased expression in patients with CF compared with control subjects demonstrated significant downregulation of genes involved in airway defense (P < 0.047) and protein metabolism (P < 0.048). This study suggests that differences in CF lung phenotype are associated with differences in expression of genes involving airway defense, protein ubiquination, and mitochondrial oxidoreductase activity and identifies specific new candidate modifiers of the CF phenotype.

Key Words: cystic fibrosis • gene expression • phenotype • respiratory epithelium

This article has been cited by other articles:

				M. P. Boyle Strategies for Identifying Modifier Genes in Cystic Fibrosis Proceedings of the ATS, January 1, 2007; 4(1): 52 - 57. [Abstract] [Full Text] [PDF]

				A. Chambellan, P. J. Cruickshank, P. McKenzie, S. B. Cannady, K. Szabo, S. A. A. Comhair, and S. C. Erzurum Gene Expression Profile of Human Airway Epithelium Induced by Hyperoxia In Vivo Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 424 - 435. [Abstract] [Full Text] [PDF]